Literature DB >> 24048444

[What must intensive care physicians know about implantable cardioverter defibrillator?].

E Gatterer1.   

Abstract

The first implantable cardioverter defibrillator (ICD) was implanted in the USA in 1980. After the publication of the landmark studies MADIT I and AVID (primary prevention in high risk patients and secondary prevention after sudden cardiac death) implantation rates dramatically increased worldwide. Due to the increasing number of implantations in elderly patients, intensive care units and emergency departments are confronted more often with patients with ICDs. Therefore, intensive care practitioners have to be familiar with these devices. This article summarizes the current literature and focuses on the management of emergencies and malfunction of ICDs.

Entities:  

Mesh:

Year:  2013        PMID: 24048444     DOI: 10.1007/s00063-013-0230-6

Source DB:  PubMed          Journal:  Med Klin Intensivmed Notfmed        ISSN: 2193-6218            Impact factor:   0.840


  29 in total

Review 1.  Permanent pacemakers and implantable defibrillators: considerations for intensivists.

Authors:  Craig A McPherson; Constantine Manthous
Journal:  Am J Respir Crit Care Med       Date:  2004-08-05       Impact factor: 21.405

2.  Comparison between atrial fibrillation-triggered implantable cardioverter-defibrillator (ICD) shocks and inappropriate shocks caused by lead failure: different impact on prognosis in clinical practice.

Authors:  Thomas Kleemann; Matthias Hochadel; Margit Strauss; Alexandros Skarlos; Karlheinz Seidl; Ralf Zahn
Journal:  J Cardiovasc Electrophysiol       Date:  2012-02-07

3.  Clinical predictors of Fidelis lead failure: report from the Canadian Heart Rhythm Society Device Committee.

Authors:  David H Birnie; Ratika Parkash; Derek V Exner; Vidal Essebag; Jeffrey S Healey; Atul Verma; Benoit Coutu; Teresa Kus; Iqwal Mangat; Felix Ayala-Paredes; Pablo Nery; George Wells; Andrew D Krahn
Journal:  Circulation       Date:  2012-02-06       Impact factor: 29.690

4.  Lead electrical parameters may not predict integrity of the Sprint Fidelis ICD lead.

Authors:  Melanie Maytin; Laurence M Epstein
Journal:  Heart Rhythm       Date:  2012-04-24       Impact factor: 6.343

5.  Impact of implanted recalled sprint Fidelis lead on patient mortality.

Authors:  Thomas B Morrison; Paul A Friedman; Linda M Kallinen; David O Hodge; Daniel Crusan; Kapil Kumar; David L Hayes; Robert F Rea; Robert G Hauser
Journal:  J Am Coll Cardiol       Date:  2011-07-12       Impact factor: 24.094

6.  Appropriate therapy but not inappropriate shocks predict survival in implantable cardioverter defibrillator patients.

Authors:  Wolfgang Dichtl; Thomas Wolber; Ursula Paoli; Simon Brüllmann; Markus Stühlinger; Thomas Berger; Karin Spuller; Alexander Strasak; Otmar Pachinger; Laurent M Haegeli; Firat Duru; Florian Hintringer
Journal:  Clin Cardiol       Date:  2011-06-15       Impact factor: 2.882

Review 7.  Clinical applications of magnets on cardiac rhythm management devices.

Authors:  Sony Jacob; Sidakpal S Panaich; Rahul Maheshwari; John W Haddad; Benzy J Padanilam; Sinoj K John
Journal:  Europace       Date:  2011-05-26       Impact factor: 5.214

8.  A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.

Authors: 
Journal:  N Engl J Med       Date:  1997-11-27       Impact factor: 91.245

9.  Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections.

Authors:  Muhammad R Sohail; Daniel Z Uslan; Akbar H Khan; Paul A Friedman; David L Hayes; Walter R Wilson; James M Steckelberg; Sarah Stoner; Larry M Baddour
Journal:  J Am Coll Cardiol       Date:  2007-04-23       Impact factor: 24.094

10.  External cardioversion of atrial fibrillation in patients with implanted pacemaker or cardioverter-defibrillator systems: a randomized comparison of monophasic and biphasic shock energy application.

Authors:  Johannes C Manegold; Carsten W Israel; Joachim R Ehrlich; Gabor Duray; Dmitri Pajitnev; Florian T Wegener; Stefan H Hohnloser
Journal:  Eur Heart J       Date:  2007-06-14       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.